The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature
Open accessAbstract
Major depressive disorder (MDD) is one of the most prevalent conditions in psychiatry. Patients who do not respond to traditional monoaminergic antidepressant treatments have an especially difficult-to-treat type of MDD termed treatment-resistant depression. Subanesthetic doses of ketamine—a glutamatergic modulator—have shown great promise for rapidly treating patients with the most severe forms of depression. As such, ketamine represents a promising probe for understanding the pathophysiology of depression and treatment response. Through neuroimaging, ketamine’s mechanism may be elucidated in humans. Here, we review 47 articles of ketamine’s effects as revealed by neuroimaging studies. Some important brain areas emerge, especially the subgenual anterior cingulate cortex. Furthermore, ketamine may decrease the ability to self-monitor, may increase emotional blunting, and may increase activity in reward processing. Further studies are needed, however, to elucidate ketamine’s mechanism of antidepressant action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Convergent data show increased PFC glucose metabolism 24-hours post-ketamine 125,126 , increased fMRI PFC activations acutely (during infusion itself) 127 , and decreased limbic responses to angry (relative to happy) faces among ketamine responders 128 .”
From Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model (2020) · cites this paper as [126]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“MDD has been shown to affect, among other areas, the PFC, the hippocampus and the anterior cingulate cortex (ACC), and there is evidence that ketamine affects these areas preferentially.204–206”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [205]
In the citing paper
“MDD has been shown to affect, among other areas, the PFC, the hippocampus and the anterior cingulate cortex (ACC), and there is evidence that ketamine affects these areas preferentially.204–206”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [205]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Brain's Default Network: Anatomy, Function, and Relevance to Disease
Buckner, R. L., Andrews‐Hanna, J. R., & Schacter, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.011 · Cited by 9,761
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
Subgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693
Mayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651
Mayberg, H. S., Brannan, S. K., Tekell, J. L., Silva, J. A., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01036-2 · Cited by 1,115
Hasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.193 · Cited by 846
Neural circuits underlying the pathophysiology of mood disorders
Price, J. L., & Drevets, W. C. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.12.011 · Cited by 788
Kohrs, R., & Durieux, M. E. (1998) · Anesthesia & Analgesia · doi:10.1097/00000539-199811000-00039 · Cited by 635
A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
Mrazek, D. A., Hornberger, J. C., Altar, C. A., & Degtiar, I. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300059 · Cited by 580 · cited 12×
“The original neuroimaging studies on ketamine’s mechanism were thus used as working models for schizophrenia because excess glutamate has been linked to the development of schizophrenia and psychosis.7 With regard to MDD patients, decreased glutamate has been noted in various prefrontal regions, including the dorsolat…”
InfluentialAuer, D. P., Pütz, B., Kraft, E., Lipinski, B., Schill, J., & Holsboer, F. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00159-6 · Cited by 562
The subcallosal cingulate gyrus in the context of major depression
Hamani, C., Mayberg, H., Stone, S., Laxton, A., Haber, S., & Lozano, A. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.034 · Cited by 508
Lener, M. S., Niciu, M. J., Ballard, E. D., Park, M., Park, L. T., Nugent, A. C., & Zarate, C. A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.005 · Cited by 468
Ketamine activates psychosis and alters limbic blood flow in schizophrenia
Lahti, A. C., Holcomb, H. H., Medoff, D. R., & Tamminga, C. A. (1995) · Neuroreport · doi:10.1097/00001756-199504190-00011 · Cited by 434
Zhang, W.-N., Chang, S.-H., Guo, L.-Y., Zhang, K.-L., & Wang, J. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.039 · Cited by 355
Deakin, J. F. W., Lees, J., McKie, S., Hallak, J. E. C., Williams, S. R., & Dursun, S. M. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.37 · Cited by 311
Rowland, L. M., Bustillo, J. R., Mullins, P. G., Jung, R. E., Lenroot, R., Landgraf, E., Barrow, R., Yeo, R., Lauriello, J., & Brooks, W. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.2.394 · Cited by 304
Ketamine : "Teaching an old drug new tricks"
Pauw, N. D. (2010) · Submitted in 2010 · Cited by 304
Ketamine Treatment and Global Brain Connectivity in Major Depression
Abdallah, C. G., Averill, L. A., Collins, K. A., Geha, P., Schwartz, J., Averill, C., DeWilde, K. E., Wong, E., Anticevic, A., Tang, C. Y., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.186 · Cited by 300
Stone, J. M., Dietrich, C., Edden, R., Mehta, M. A., De Simoni, S., Reed, L. J., Krystal, J. H., Nutt, D., & Barker, G. J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.171 · Cited by 295
Do the dissociative side effects of ketamine mediate its antidepressant effects?
Luckenbaugh, D. A., Niciu, M. J., Ionescu, D. F., Nolan, N. M., Richards, E. M., Brutsche, N. E., Guevara, S., & Zarate, C. A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.017 · Cited by 283
Self-citationScheidegger, M., Walter, M., Lehmann, M., Metzger, C., Grimm, S., Boeker, H., Boesiger, P., Henning, A., & Seifritz, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044799 · Cited by 282
HCN1 Channel Subunits Are a Molecular Substrate for Hypnotic Actions of Ketamine
Chen, X., Shu, S., & Bayliss, D. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3481-08.2009 · Cited by 278
Salvadore, G., Cornwell, B. R., Colon-Rosario, V., Coppola, R., Grillon, C., Zarate, C. A., & Manji, H. K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.014 · Cited by 277
Lally, N., Nugent, A. C., Luckenbaugh, D. A., Ameli, R., Roiser, J. P., & Zarate, C. A. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.105 · Cited by 271
Phillips, M. L., Chase, H. W., Sheline, Y. I., Etkin, A., Almeida, J. R. C., Deckersbach, T., & Trivedi, M. H. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010076 · Cited by 267
Self-citationDuman, R. S. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.1/rduman · Cited by 249
Muthukumaraswamy, S. D., Shaw, A. D., Jackson, L. E., Hall, J., Moran, R., & Saxena, N. K. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0903-15.2015 · Cited by 237
Ketamine: review of its pharmacology and its use in pediatric anesthesia.
Bergman, S. A. (1999) · PubMed Central · Cited by 234
Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: A meta-analysis
Yildiz-Yesiloglu, A., & Ankerst, D. P. (2006) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2005.12.004 · Cited by 232
Neural correlates of change in major depressive disorder anhedonia following open-label ketamine
Lally, N., Nugent, A. C., Luckenbaugh, D. A., Niciu, M. J., Roiser, J. P., & Zarate, C. A. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114568041 · Cited by 224
Salvadore, G., Cornwell, B. R., Sambataro, F., Latov, D. R., Colon-Rosario, V., Carver, F. W., Holroyd, T., Diazgranados, N., Machado‐Vieira, R., Grillon, C., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.24 · Cited by 220
Mechanism of action of ketamine
Stahl, S. M. (2013) · CNS Spectrums · doi:10.1017/s109285291300045x · Cited by 218
Bonhomme, V., Vanhaudenhuyse, A., Demertzi, A., Bruno, M.-A., Jaquet, O., Bahri, M. A., Plenevaux, A., Boly, M., Boveroux, P., Soddu, A., et al. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001275 · Cited by 207
Valentine, G. W., Mason, G. F., Gomez, R., Fasula, M. K., Watzl, J., Pittman, B. P., Krystal, J. H., & Sanacora, G. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2010.10.009 · Cited by 205
Cornwell, B. R., Salvadore, G., Furey, M., Marquardt, C. A., Brutsché, N. E., Grillon, C., & Zarate, C. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.029 · Cited by 205
Iadarola, N. D., Niciu, M. J., Richards, E. M., Vande Voort, J. L., Ballard, E. D., Lundin, N. B., Nugent, A. C., Machado-Vieira, R., & Zarate, C. A. (2015) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622315579059 · Cited by 201
Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia
Kraguljac, N. V., White, D. M., Reid, M. A., & Lahti, A. C. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.2437 · Cited by 191
Carlson, P. J., Diazgranados, N., Nugent, A. C., Ibrahim, L., Luckenbaugh, D. A., Brutsche, N., Herscovitch, P., Manji, H. K., Zarate, C. A., & Drevets, W. C. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.008 · Cited by 168
Rivolta, D., Heidegger, T., Scheller, B., Sauer, A., Schaum, M., Birkner, K., Singer, W., Wibral, M., & Uhlhaas, P. J. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv051 · Cited by 149
Driesen, N. R., McCarthy, G., Bhagwagar, Z., Bloch, M. H., Calhoun, V. D., D'Souza, D. C., Gueorguieva, R., He, G., Leung, H.-C., Ramani, R., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.170 · Cited by 148
Niesters, M., Khalili-Mahani, N., Martini, C., Aarts, L., van Gerven, J., van Buchem, M. A., Dahan, A., & Rombouts, S. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31826a0db3 · Cited by 147
Milak, M. S., Proper, C. J., Mulhern, S. T., Parter, A. L., Kegeles, L. S., Ogden, R. T., Mao, X., Rodriguez, C. I., Oquendo, M. A., Suckow, R. F., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.83 · Cited by 144
Rogers, R., Wise, R. G., Painter, D., Longe, S., & Tracey, I. (2004) · Anesthesiology · doi:10.1097/00000542-200402000-00018 · Cited by 131
Ketamine amplifies induced gamma frequency oscillations in the human cerebral cortex
Shaw, A. D., Saxena, N., E. Jackson, L., Hall, J. E., Singh, K. D., & Muthukumaraswamy, S. D. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.04.012 · Cited by 122
Ketamine enantiomers in the rapid and sustained antidepressant effects
Muller, J., Pentyala, S., Dilger, J., & Pentyala, S. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316631267 · Cited by 122
Ketamine as a promising prototype for a new generation of rapid‐acting antidepressants
Abdallah, C. G., Averill, L. A., & Krystal, J. H. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12718 · Cited by 121
Honey, G. D., Honey, R. A. E., O'Loughlin, C., Sharar, S. R., Kumaran, D., Suckling, J., Menon, D. K., Sleator, C., Bullmore, E. T., & Fletcher, P. C. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh176 · Cited by 119
Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate
Downey, D., Dutta, A., McKie, S., Dawson, G. R., Dourish, C. T., Craig, K., Smith, M. A., McCarthy, D. J., Harmer, C. J., Goodwin, G. M., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.006 · Cited by 116
Doyle, O., Simoni, S. D., Schwarz, A. J., Brittain, C., O’Daly, O., Williams, S., & Mehta, M. A. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201665 · Cited by 115
Salvadore, G., van der Veen, J. W. C., Zhang, Y., Marenco, S., Machado‐Vieira, R., Baumann, J., Ibrahim, L. A., Luckenbaugh, D. A., Shen, J., Drevets, W. C., et al. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001593 · Cited by 111
Murrough, J. W., Collins, K. A., Fields, J., DeWilde, K. E., Phillips, M. L., Mathew, S. J., Wong, E., Tang, C. Y., Charney, D. S., & Iosifescu, D. V. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.10 · Cited by 109
Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study
Abel, K. M., Allin, M. P. G., Kucharska‐Pietura, K., David, A. S., Andrew, C., Williams, S., Brammer, M. J., & Phillips, M. L. (2003) · Neuroreport · doi:10.1097/00001756-200303030-00018 · Cited by 109
Honey, R. A. E., Honey, G. D., O'Loughlin, C., Sharar, S. R., Kumaran, D., Bullmore, E. T., Menon, D. K., Donovan, T., Lupson, V., Bisbrown-Chippendale, R., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300438 · Cited by 105
Kraguljac, N. V., Frölich, M. A., Tran, S., White, D. M., Nichols, N., Barton-McArdle, A., Reid, M. A., Bolding, M., & Lahti, A. C. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.122 · Cited by 102
Grimm, O., Gass, N., Weber‐Fahr, W., Sartorius, A., Schenker, E., Spedding, M., Risterucci, C., Schweiger, J. I., Böhringer, A., Zang, Z., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4022-y · Cited by 93
Neural correlates of rapid antidepressant response to ketamine in bipolar disorder
Nugent, A. C., Diazgranados, N., Carlson, P. J., Ibrahim, L. A., Luckenbaugh, D. A., Brutsché, N. E., Herscovitch, P., Drevets, W. C., & Zarate, C. A. (2013) · Bipolar Disorders · doi:10.1111/bdi.12118 · Cited by 86
Ketamine effects on brain function — Simultaneous fMRI/EEG during a visual oddball task
Musso, F., Brinkmeyer, J., Ecker, D., London, M. K., Thieme, G., Warbrick, T., Wittsack, H., Saleh, A., Greb, W., de Boer, P., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.06.045 · Cited by 80
Ketamine administration reduces amygdalo‐hippocampal reactivity to emotional stimulation
Scheidegger, M., Henning, A., Walter, M., Lehmann, M., Kraehenmann, R., Boeker, H., Seifritz, E., & Grimm, S. (2016) · Human Brain Mapping · doi:10.1002/hbm.23148 · Cited by 79
Neural Correlates of Suicidal Ideation and Its Reduction in Depression
Ballard, E. D., Lally, N., Nugent, A. C., Furey, M. L., Luckenbaugh, D. A., & Zarate, C. A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu069 · Cited by 78
Hippocampal volume and the rapid antidepressant effect of ketamine
Abdallah, C. G., Salas, R., Jackowski, A., Baldwin, P., Sato, J. R., & Mathew, S. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114544776 · Cited by 78
Joules, R., Doyle, O., Schwarz, A. J., O’Daly, O., Brammer, M. J., Williams, S., & Mehta, M. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3951-9 · Cited by 76
Taylor, M. J., Tiangga, E. R., Mhuircheartaigh, R. N., & Cowen, P. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111405359 · Cited by 66
Effects of ketamine on cognition–emotion interaction in the brain
Scheidegger, M., Henning, A., Walter, M., Boeker, H., Weigand, A., Seifritz, E., & Grimm, S. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2015.08.070 · Cited by 64
Structural connectivity and response to ketamine therapy in major depression: A preliminary study
Vasavada, M. M., Leaver, A. M., Espinoza, R. T., Joshi, S. H., Njau, S. N., Woods, R. P., & Narr, K. L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.11.018 · Cited by 60
Lehmann, M., Seifritz, E., Henning, A., Walter, M., Böker, H., Scheidegger, M., & Grimm, S. (2016) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsw034 · Cited by 57
Abel, K. M., Allin, M. P. G., Kucharska‐Pietura, K., Andrew, C., Williams, S., David, A. S., & Phillips, M. L. (2002) · Human Brain Mapping · doi:10.1002/hbm.10064 · Cited by 55
Fu, C. H. Y., Abel, K. M., Allin, M. P. G., Gasston, D., Costafreda, S. G., John Suckling, A., Williams, S., & McGuire, P. K. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0154-9 · Cited by 52
Khalili‐Mahani, N., Niesters, M., van Osch, M. J. P., Oitzl, M. S., Veer, I. M., de Rooij, M., van Gerven, J., van Buchem, M. A., Beckmann, C. F., Rombouts, S. A. R. B., et al. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.12.050 · Cited by 50
Multistage drug effects of ketamine in the treatment of major depression
Walter, M., Li, S., & Demenescu, L. R. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0535-3 · Cited by 49
Ketamine-dependent neuronal activation in healthy volunteers
Höflich, A. S., Hahn, A., Küblböck, M., Kranz, G. S., Vanicek, T., Ganger, S., Spies, M., Windischberger, C., Kasper, S. F., Winkler, D., et al. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1291-0 · Cited by 45
Nugent, A. C., Robinson, S. E., Coppola, R., & Zarate, C. A. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.06.006 · Cited by 42
Wong, J. J., O’Daly, O., Mehta, M. A., Young, A. H., & Stone, J. M. (2016) · PeerJ · doi:10.7717/peerj.1710 · Cited by 39
Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency
Nagels, A., Kirner-Veselinovic, A., Krach, S., & Kircher, T. T. J. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.08.021 · Cited by 37
François, J., Grimm, O., Schwarz, A. J., Schweiger, J. I., Haller, L., Risterucci, C., Böhringer, A., Zang, Z., Tost, H., Gilmour, G., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.291 · Cited by 34
[Mechanism of action of ketamine].
Vl, V., Tg, E., Vi, A., & Sp, N. (1983) · PubMed · Cited by 27
Stone, J. M., Kotoula, V., Dietrich, C., Simoni, S. D., Krystal, J. H., & Mehta, M. A. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115592337 · Cited by 24
Shcherbinin, S., Doyle, O., Zelaya, F. O., Simoni, S. D., Mehta, M. A., & Schwarz, A. J. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4021-z · Cited by 21
Ketamine-Induced Disruption of Verbal Self-Monitoring Linked to Superior Temporal Activation
Stone, J. M., Abel, K. M., Allen, M. P. G., van Haren, N. E. M., Matsumoto, K., McGuire, P. K., & Fu, C. H. Y. (2010) · Pharmacopsychiatry · doi:10.1055/s-0030-1267942 · Cited by 18
Cited by
Sorted by citations
Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model
Price, R. B., & Duman, R. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0615-x · Cited by 739
Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209
The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders
Sanacora, G., Yan, Z., & Popoli, M. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00540-x · Cited by 197
Alexander, L., Wood, C. M., Gaskin, P. L. R., Sawiak, S. J., Fryer, T. D., Hong, Y. T., McIver, L., Clarke, H. F., & Roberts, A. C. (2020) · Nature Communications · doi:10.1038/s41467-020-19167-0 · Cited by 100
Mathai, D. S., Meyer, M. J., Storch, E. A., & Kosten, T. R. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.12.023 · Cited by 97
Metadata
- Authors
- Ionescu, D. F., Felicione, J. M., Gosai, A., Cusin, C., Shin, P., Shapero, B. G., & Deckersbach, T.
- Affiliations
- Harvard University (US)
- Corresponding author
- Cusin, Cristina
- Venue
- Harvard Review of Psychiatry
- Published
- 2018-11
- Volume
- 26
- Issue
- 6
- Pages
- 320-339
- ISSN
- 1067-3229 (ISSN-L)
- 1465-7309
- PMC
- PMC6102096
- OpenAlex
- W2794329512
- Cited by
- 91
- References
- 82
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 11 · 2023: 17 · 2022: 11 · 2021: 17 · 2020: 12 · 2019: 10 · 2018: 2
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Harvard Review of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R01MH102279, K23MH107776)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- ketamine, treatment-resistant depression, major depressive disorder, subgenual anterior cingulate cortex, self-monitoring, emotional blunting, reward processing, antidepressant mechanism, glutamatergic modulation, neuroimaging of depression
- MeSH terms
- Antidepressive Agents, Cerebral Cortex, Major Depressive Disorder, Humans, Ketamine, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review